Loading...
XSHG603585
Market cap309mUSD
Dec 27, Last price  
12.27CNY
1D
2.00%
1Q
9.26%
Jan 2017
-68.32%
IPO
-47.96%
Name

Suli Co Ltd

Chart & Performance

D1W1MN
XSHG:603585 chart
P/E
112.36
P/S
1.15
EPS
0.11
Div Yield, %
4.39%
Shrs. gr., 5y
0.23%
Rev. gr., 5y
3.54%
Revenues
1.96b
-37.84%
679,434,117716,212,277813,425,696890,096,0471,122,807,6981,350,565,2501,456,615,0151,645,899,0471,812,605,5551,558,610,0292,291,648,7173,150,170,7521,958,208,461
Net income
20m
-93.63%
35,487,45360,076,74359,427,18668,806,432118,097,531185,256,877308,770,551426,176,161407,949,553174,747,119241,432,485315,328,47420,076,565
CFO
216m
-58.34%
066,596,231165,419,165176,042,567147,068,573236,838,547284,550,206420,486,858486,332,393169,057,787316,004,317519,443,185216,380,552
Dividend
Jul 01, 20240.05 CNY/sh
Earnings
May 22, 2025

Profile

Suli Co., Ltd. researches, produces, and sells agrochemicals, flame retardants, pharmaceutical intermediates, and other fine chemicals. The company offers chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid technical products; pesticide formulations; and decabromodiphenyl ethane. It also provides brominated, environment-friendly, and halogen-free flame retardants; and intermediates, including trichloroacetonitrile, tetrachlorophthalonitrile, pentachloropyridine, pentachlorobenzonitrile, isophthalodinitrile, and hydrobromic acid, as well as 1,2-diphenylethane and 1,2-dibromoethane. In addition, the company offers industry biocides, such as Longee 985CHL, 550CCD, 550CC, and 500CHL; and ferric chloride solution for use in water treatment. It sells its products under the Suli brand name for use in agricultural production, and plastics and building materials industries, etc. in European Union, North America, South America, Africa, Southeast Asia, and other countries. Suli Co., Ltd. is based in Jiangyin, China.
URL
http://www.suli.com
IPO date
Dec 14, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,958,208
-37.84%
3,150,171
37.46%
2,291,649
47.03%
Cost of revenue
1,857,480
2,621,535
1,899,191
Unusual Expense (Income)
NOPBT
100,729
528,636
392,457
NOPBT Margin
5.14%
16.78%
17.13%
Operating Taxes
5,897
66,209
44,675
Tax Rate
5.85%
12.52%
11.38%
NOPAT
94,832
462,427
347,783
Net income
20,077
-93.63%
315,328
30.61%
241,432
38.16%
Dividends
(99,001)
(54,000)
Dividend yield
3.79%
1.56%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
90,148
37,426
37,071
Long-term debt
1,085,227
879,592
8,549
Deferred revenue
60,883
44,361
9,068
Other long-term liabilities
61,648
1
3,824
Net debt
(206,444)
(1,227,459)
(1,169,178)
Cash flow
Cash from operating activities
216,381
519,443
316,004
CAPEX
(661,434)
Cash from investing activities
(640,921)
Cash from financing activities
(189,749)
917,454
FCF
(922,672)
(102,537)
342,896
Balance
Cash
1,326,142
1,944,267
1,137,324
Long term investments
55,677
200,210
77,475
Excess cash
1,283,908
1,986,968
1,100,216
Stockholders' equity
2,640,582
2,775,967
2,133,388
Invested Capital
3,150,104
2,266,238
1,632,379
ROIC
3.50%
23.72%
21.93%
ROCE
2.26%
12.42%
14.36%
EV
Common stock shares outstanding
182,514
211,619
180,000
Price
14.31
-19.29%
17.73
-7.56%
19.18
3.12%
Market cap
2,611,779
-30.39%
3,752,000
8.68%
3,452,400
3.12%
EV
3,131,622
3,250,307
2,778,401
EBITDA
230,379
648,683
495,868
EV/EBITDA
13.59
5.01
5.60
Interest
29,766
21,966
523
Interest/NOPBT
29.55%
4.16%
0.13%